SCOTUS Sends False Claims Drug Pricing Case Back to Lower Court

The U.S. Supreme Court on Thursday sent back to a lower court two cases involving a pair of supermarkets accused of overcharging the federal government for prescription drugs in violation of the False Claims Act.
Source: Drug Industry Daily